Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
134 ARTÍCULOS , VIENDO DEL 16 AL 30
Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection
Risacher SL, Saykin AJ.
Annu Rev Clin Psychol. 2013;9:621-48. doi: 10.1146/annurev-clinpsy-050212-185535. Epub 2013 Jan 7.
Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes
Delvaux E, Bentley K, Stubbs V, Sabbagh M, Coleman PD.
Neurobiol Aging. 2013 Jun;34(6):1680-6. doi: 10.1016/j.neurobiolaging.2012.12.004. Epub 2013 Jan 5.
Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers
Kosicek M, Hecimovic S.
Int J Mol Sci. 2013 Jan 10;14(1):1310-22. doi: 10.3390/ijms14011310.
Plasma proteomics for the identification of Alzheimer disease
Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.
Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):337-42. doi: 10.1097/WAD.0b013e31827b60d2.
Mangialasche F, Westman E, Kivipelto M, Muehlboeck JS, Cecchetti R, Baglioni M, Tarducci R, Gobbi G, Floridi P, Soininen H, Kłoszewska I, Tsolaki M, Vellas B, Spenger C, Lovestone S, Wahlund LO, Simmons A, Mecocci P; AddNeuroMed consortium.
J Intern Med. 2013 Jun;273(6):602-21. doi: 10.1111/joim.12037. Epub 2013 Feb 28.
A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease
Peters KR, Lynn Beattie B, Feldman HH, Illes J.
Prog Neurobiol. 2013 Nov;110:114-23. doi: 10.1016/j.pneurobio.2012.12.001. Epub 2013 Jan 21.
State of the science: use of biomarkers and imaging in diagnosis and management of Alzheimer disease
Fraller DB.
J Neurosci Nurs. 2013 Apr;45(2):63-70. doi: 10.1097/JNN.0b013e3182829024.
Fulop T, Lacombe G, Cunnane S, Le Page A, Dupuis G, Frost EH, Bourgade-Navarro K, Goldeck D, Larbi A, Pawelec G.
Discov Med. 2013 Jan;15(80):33-42.
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB.
Neurology. 2013 Mar 12;80(11):1048-56. doi: 10.1212/WNL.0b013e3182872830. Epub 2013 Feb 6.
Alzheimer disease biomarkers and insights into mild cognitive impairment
Knopman DS.
Neurology. 2013 Mar 12;80(11):978-80. doi: 10.1212/WNL.0b013e31828728ac. Epub 2013 Feb 6.
Rosenberg PB, Wong DF, Edell SL, Ross JS, Joshi AD, Brašić JR, Zhou Y, Raymont V, Kumar A, Ravert HT, Dannals RF, Pontecorvo MJ, Skovronsky DM, Lyketsos CG.
Am J Geriatr Psychiatry. 2013 Mar;21(3):272-8. doi: 10.1016/j.jagp.2012.11.016.
Genetic study of neurexin and neuroligin genes in Alzheimer's disease
Martinez-Mir A, González-Pérez A, Gayán J, Antúnez C, Marín J, Boada M, Lopez-Arrieta JM, Fernández E, Ramírez-Lorca R, Sáez ME, Ruiz A, Scholl FG, Real LM.
J Alzheimers Dis. 2013;35(2):403-12. doi: 10.3233/JAD-122257.
Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease
Perneczky R, Guo LH, Kagerbauer SM, Werle L, Kurz A, Martin J, Alexopoulos P.
Transl Psychiatry. 2013 Feb 19;3(2):e227. doi: 10.1038/tp.2013.11.
Imaging epigenetics in Alzheimer's disease
Lista S, Garaci FG, Toschi N, Hampel H.
Curr Pharm Des. 2013;19(36):6393-415. doi: 10.2174/13816128113199990370.
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI
Vos SJ, van Rossum IA, Verhey F, Knol DL, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Frisoni GB, Froelich L, Nobili F, van der Flier W, Blennow K, Wolz R, Scheltens P, Visser PJ.
Neurology. 2013 Mar 19;80(12):1124-32. doi: 10.1212/WNL.0b013e318288690c. Epub 2013 Feb 27.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.